The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
Open accessAbstract
Significance: New chemical entities (NCEs) with desired pharmacological and biological activity spectra fuel drug discovery and provide tools for chemical biologists. Computer-assisted molecular design generates novel chemotypes with predictable polypharmacologies. We present the successful application of fully automated de novo drug design coupled with a pioneering approach for target panel prediction to obtain readily synthesizable bioactive compounds. This innovative concept enabled the identification of relevant macromolecular targets of computationally designed NCEs and led to the discovery of previously unknown off-targets of approved drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Charifson, P. S., Corkery, J. J., Murcko, M. A., & Walters, W. P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990352k · Cited by 698
Can we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
Hartenfeller, M., Zettl, H., Walter, M., Rupp, M., Reisen, F., Proschak, E., Weggen, S., Stark, H., & Schneider, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002380 · Cited by 251 · cited 3×
“Using the unsupervised SOM al-gorithm, we clustered 12,661 manually annotated, pharmaceuti-cally relevant drugs and lead compounds [collection of bioactive reference analogs (COBRA); inSili.com LLC] (33).”
MethodSelf-citation
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“…ed/) [140], Self-Organizing Map Based Prediction of Drug Equivalence Relationship (SPiDER) (http:// modla bcadd. ethz . ch/ softw are/ spider) [357], Targethunter (https:// www. cblig and. org / Targe tHunt er3D/) [358], PharmMapper (http:// lilab-ecust. cn / pharm mapper/) [359], ChemMapper…”
BackgroundCounting on natural products for drug design
Rodrigues, T., Reker, D., Schneider, P., & Schneider, G. (2016) · Nature Chemistry · doi:10.1038/nchem.2479 · Cited by 1,250
Self-citationNatural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,241
Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citation
Metadata
- Authors
- Reker, D., Rodrigues, T., Schneider, P., & Schneider, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-03-03
- Volume
- 111
- Issue
- 11
- Pages
- 4067-4072
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2010453137
- Cited by
- 227
- References
- 5
- FWCI
- 22.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. https://app.cochat.ai/papers/10.1073/pnas.1320001111
- The paper
- Reker, D., Rodrigues, T., Schneider, P., & Schneider, G. (2014). Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1320001111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.